María Villalba

1.8k total citations · 1 hit paper
35 papers, 959 citations indexed

About

María Villalba is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, María Villalba has authored 35 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in María Villalba's work include Ferroptosis and cancer prognosis (4 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). María Villalba is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). María Villalba collaborates with scholars based in Spain, United States and United Kingdom. María Villalba's co-authors include Alfonso Calvo, Carlos E. de Andrea, Ignacio Melero, Miguel F. Sanmamed, Miriam Redrado, Kurt A. Schalper, Fernando Vidal‐Vanaclocha, María C. Ochoa, Álvaro Teijeira and Iñaki Eguren‐Santamaría and has published in prestigious journals such as Annals of Neurology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

María Villalba

35 papers receiving 948 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach

2025 21 citations María Villalba, Miguel F. Sanmamed et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María Villalba Spain	20	407	366	341	232	143	35	959
Anna Passarelli Italy	14	400 1.0×	426 1.2×	365 1.1×	183 0.8×	113 0.8×	34	880
Adam Cooper Australia	16	318 0.8×	669 1.8×	292 0.9×	303 1.3×	257 1.8×	38	1.1k
Yuan Mao China	20	497 1.2×	445 1.2×	266 0.8×	152 0.7×	123 0.9×	58	946
Yacine Barèche Belgium	14	321 0.8×	600 1.6×	249 0.7×	356 1.5×	197 1.4×	24	1.0k
Anna-Maria Larsson Sweden	14	232 0.6×	480 1.3×	226 0.7×	345 1.5×	135 0.9×	27	859
И. Г. Козлов Russia	7	339 0.8×	413 1.1×	258 0.8×	223 1.0×	276 1.9×	43	852
Michiko Harao Japan	16	362 0.9×	329 0.9×	377 1.1×	132 0.6×	88 0.6×	36	915
Andrew N. Stephens Australia	17	304 0.7×	342 0.9×	221 0.6×	162 0.7×	81 0.6×	32	892
Jörn Dietrich Germany	20	706 1.7×	465 1.3×	308 0.9×	242 1.0×	187 1.3×	33	1.1k
Mildred Felder United States	17	445 1.1×	421 1.2×	467 1.4×	157 0.7×	86 0.6×	39	1.1k

Countries citing papers authored by María Villalba

Since Specialization

Citations

This map shows the geographic impact of María Villalba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Villalba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Villalba more than expected).

Fields of papers citing papers by María Villalba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Villalba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Villalba. The network helps show where María Villalba may publish in the future.

Co-authorship network of co-authors of María Villalba

This figure shows the co-authorship network connecting the top 25 collaborators of María Villalba. A scholar is included among the top collaborators of María Villalba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Villalba. María Villalba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Villalba, María, et al.. (2025). Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach. Nature Reviews Clinical Oncology. 22(3). 163–181. 21 indexed citations breakdown →

López‐Janeiro, Álvaro, María Villalba, Mikel Ariz, et al.. (2023). Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images. npj Digital Medicine. 6(1). 48–48. 5 indexed citations

Palanca-Ballester, Cora, David Hervás, María Villalba, et al.. (2022). Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer. Clinical Epigenetics. 14(1). 116–116. 9 indexed citations

Meraviglia-Crivelli, Daniel, Helena Villanueva, María Villalba, et al.. (2022). IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction. Molecular Cancer. 21(1). 211–211. 19 indexed citations

Meraviglia-Crivelli, Daniel, et al.. (2022). A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression. Molecular Therapy — Nucleic Acids. 29. 413–425. 18 indexed citations

López‐Janeiro, Álvaro, Ignacio Ruz‐Caracuel, Vivian de los Rı́os, et al.. (2021). Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling. Cancers. 13(4). 794–794. 36 indexed citations

Álvarez, Maite, Carmen Molina, Carlos E. de Andrea, et al.. (2021). Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy. Journal for ImmunoTherapy of Cancer. 9(11). e002953–e002953. 29 indexed citations

García-Moure, Marc, Jaime Gállego Pérez‐Larraya, Ana Patiño‐García, et al.. (2021). EPCT-04. RESULTS OF A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 WITH RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). Neuro-Oncology. 23(Supplement_1). i47–i47. 1 indexed citations

Teijeira, Álvaro, Saray Garasa, María C. Ochoa, et al.. (2020). IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy. Clinical Cancer Research. 27(9). 2383–2393. 162 indexed citations

10.

Soldevilla, Mario Martínez, Helena Villanueva, Daniel Meraviglia-Crivelli, et al.. (2019). ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity. Molecular Therapy. 27(11). 1878–1891. 43 indexed citations

11.

Expósito, Francisco, María Villalba, Miriam Redrado, et al.. (2019). Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery. Cancer Letters. 453. 21–33. 27 indexed citations

12.

Redín, Esther, María Villalba, Francisco Expósito, et al.. (2019). P2.03-38 Identification of a Novel Synthetic Lethal Vulnerability in Non-Small Cell Lung Cancer by Co-Targeting TMPRSS4 and DDR1. Journal of Thoracic Oncology. 14(10). S698–S699. 1 indexed citations

13.

Villalba, María, Francisco Expósito, María J. Pajares, et al.. (2019). TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients. Journal of Clinical Medicine. 8(12). 2134–2134. 18 indexed citations

14.

Expósito, Francisco, María Villalba, María J. Pajares, et al.. (2018). P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC. Journal of Thoracic Oncology. 13(10). S521–S521. 2 indexed citations

15.

Bleau, Anne‐Marie, Miriam Redrado, Estanislao Nistal‐Villán, et al.. (2017). miR-146a targets c-met and abolishes colorectal cancer liver metastasis. Cancer Letters. 414. 257–267. 45 indexed citations

16.

Marí‐Alexandre, Josep, Ángel Díaz‐Lagares, María Villalba, et al.. (2017). Translating cancer epigenomics into the clinic: focus on lung cancer. Translational research. 189. 76–92. 38 indexed citations

17.

Ruiz‐Irastorza, Guillermo, M Garcia, Gerard Espinosa, et al.. (2016). First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort. Lupus Science & Medicine. 3(1). e000153–e000153. 23 indexed citations

18.

Villalba, María, Ángel Díaz‐Lagares, Miriam Redrado, et al.. (2016). TMPRSS4 protein overexpression and its promoter hypomethylation predict poor prognosis in squamous lung cancer patients. European Journal of Cancer. 61. S14–S14. 1 indexed citations

19.

Manrique, Irene, Paul Nguewa, Anne‐Marie Bleau, et al.. (2014). The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties. Cancer Letters. 356(2). 899–909. 28 indexed citations

20.

Sabater, Juan & María Villalba. (1972). Creatine phosphokinase (CPK) levels in umbilical cord blood. Clinica Chimica Acta. 36(1). 201–206. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact